Gastrodin, the main compound of the Chinese orchid tianma, calms nerve signaling and reduces inflammation. Best-supported human uses are headache and dizziness; it modestly lowers blood pressure as an add-on and reduced short-term confusion after heart surgery. Brain-protection claims for aging rest on lab and animal work, not yet confirmed in people. (Full Review)

Protocol

Standard Oral Dose

100–600 mg/day

Often ~300 mg per capsule; start low and titrate slowly

Dosing Frequency

Divided, 2–3× daily

Short ~1-hour half-life favors split over single dosing

Best Time of Day

Evening or split

Mildly sedative; daytime reasonable for headache or vertigo

Time to effect

Headache or Dizziness

Days to a few weeks

Reported in clinical use with consistent dosing

Brain Protection

Not established

No meaningful timeframe established in humans

Benefits

Medium: Migraine and tension-type headache reduction; vertigo and dizziness relief

Low: Blood pressure lowering; prevention of postoperative delirium and cognitive decline

Speculative: Neuroprotection in Alzheimer's and Parkinson's disease; sleep quality and mood support; general antioxidant and organ protection

Contraindications

Pregnant or breastfeeding individuals

Known allergy to Gastrodia elata

Bleeding disorder, or surgery within 1–2 weeks

Baseline hypotension (symptomatic low blood pressure) without medical guidance

Key Interactions

Prescription sedatives and CNS depressants (benzodiazepines, Z-drugs, barbiturates, opioids)

Antihypertensive medications (ACE inhibitors, ARBs, calcium-channel blockers, beta-blockers)

Anticoagulants and antiplatelet drugs (warfarin, apixaban, rivaroxaban, aspirin, clopidogrel)

OTC sedating antihistamines (diphenhydramine), OTC sleep aids, and alcohol

Calming or GABAergic supplements (valerian, kava, L-theanine, magnesium, melatonin)

Blood-pressure-lowering supplements (magnesium, CoQ10, garlic extract) and cerebral-blood-flow agents (Ginkgo biloba)

Betahistine

Risk & Side Effects

Medium: Under-reported safety data

Low: Mild gastrointestinal upset; sedation and dizziness; injection-site and hypersensitivity reactions

Speculative: Excessive blood-pressure or blood-thinning effects; unknown long-term and pregnancy safety

Monitoring

Marker	Target	Why
Blood pressure	~110–125 / 70–80 mmHg	Detect additive blood-pressure lowering and track an actual target if used for hypertension
Resting heart rate	55–70 bpm	Screen for excessive cardiovascular slowing when combined with other agents
Liver enzymes (ALT, AST)	ALT < 25 U/L (men), < 20 U/L (women)	Confirm no liver stress with an unregulated botanical taken chronically
Complete blood count (CBC)	Within normal limits, stable platelets	Baseline before any agent with theoretical antiplatelet activity
Fasting glucose / HbA1c	Glucose 75–90 mg/dL; HbA1c < 5.4%	Context for cognitive-protection goals, since metabolic health drives brain aging

Cadence: Baseline before first dose; recheck blood pressure at 1–2 weeks (especially if on antihypertensives); reassess symptoms and safety labs at 8–12 weeks, then every 6–12 months if use continues.

Qualitative Assessment

Headache frequency, severity, and duration (a simple headache diary is the most relevant tracker)
Frequency and intensity of dizziness or vertigo episodes
Sleep onset and sleep quality
Daytime mental clarity, focus, and sense of calm versus over-sedation or grogginess
Mood and perceived stress resilience

Gastrodin for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment